Acute Coronary Syndromes: A Handbook for Clinical Practice
February 2009, Wiley-Blackwell
International experts address the different aspects of NSTE-ACS and bring useful information to clinicians, interventionalists and surgeons involved in the difficult management of these patients.
The ESC Education Series
This book is part of the ESC Education Series. The series is designed to provide medical professionals with the latest information about the understanding, diagnosis and management of cardiovascular diseases. Where available, management recommendations are based on the established European Guidelines, which encompass the best techniques to use with each cardiac disease. Throughout the series, the leading international opinion leaders have been chosen to edit and contribute to the books. The information is presented in a succinct and accessible format with a clinical focus.
Section one: Epidemiology.
1 Epidemiology of non-ST-segment elevation acute coronary syndromes.
David Hasdai and Alexander Battler.
Section two: Pathophysiology.
2 Pathologic findings in acute coronary syndromes.
3 Vascular biology of acute coronary syndromes.
Section three: Clinical aspects of ACS.
4 Clinical aspects of acute coronary syndromes.
5 Circulating biomarkers for risk stratification.
Section four: Investigation in ACS.
6 Coronary angiography, angioscopy, and intravascular ultrasound in non-ST segment elevation acute coronary syndromes.
Eric Van Belle, Christophe Bauters, François Schiele, and Michel E. Bertrand.
7 New coronary imaging in acute coronary syndrome.
Pim J. de Feyter, Evelyne Regar, and Nico R.A. Mollet.
Section five: Special groups of patients.
8 Acute coronary syndromes in special groups of patients.
Piero O. Bonetti, Michael J. Zellweger, Christoph Kaiser, and Matthias E. Pfisterer.
Section six: Pharmacological treatment.
9 Antiischemic treatment (nitrates, β-blockers, calcium antagonists).
David McCarty, Colum G. Owens, and A.A. Jennifer Adgey.
10 Antiplatelet therapies: aspirin, thienopyridines, and glycoprotein IIb/IIIa receptor inhibitors.
Jaydeep Sarma and Keith A.A. Fox.
11 Antithrombin drugs: LMWH, unfractionated heparin, direct thrombin inhibitors .
Raphaelle Dumaine and Gilles Montalescot.
12 Statin therapy in ACS.
Section seven: Myocardial revascularization.
13 Percutaneouscoronary interventionsand stenting/CABG in non-ST-segment elevation acute coronary syndromes.
Nicolas Meneveau and Jean-Pierre Bassand.
Section eight: Therapeutic strategy.
14 Risk stratification and therapeutic strategy.
Christian W. Hamm.
15 Indication for revascularization in non-ST-elevation acute coronary syndrome.
16 Management of patientswith nonamenable lesions for myocardial revascularization.
17 Non-ST-segment elevation coronary syndromes: European Society of Cardiology guidelines.
Michel E. Bertrand.
18 Non-ST-segment elevation acute coronary syndromes: ACC/AHA guidelines.
19 From guidelines to registries.
Section nine: Secondary prevention.
20 Secondary prevention after acute episode of patients presenting with nonpersistent ST-segment elevation.
Michel E. Bertrand.
21 How to detect vulnerable plaque.
Dirk Boese and Raimund Erbel.
22 Local versus systemic prevention treatment.
Mario Togni and Bernhard Meier.
Dr Spencer King III, Fuqua Chair of Interventional Cardiolo, Fuqua institute, Atlanta, GA, USA
- Part of the ESC Education Series
- Based on the established European Guidelines
- Edited by leading international opinion leaders
- Succinct and accessible format with a clinical focus
- Covers the latest developments in acute coronary syndromes
- Addresses all the different aspects of NSTE-ACS